Table 5 Prevalence of each gene and relationship between each gene and clinical outcomes in Japan
| Â | Total | Â | gastritis | Â | DU | Â | Â | GU | Â | Â | GC | Â | Â |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
n | 169 | Â | 49 | Â | 50 | Â | P | 50 | Â | P | 20 | Â | P |
mean age | 60.0 ± 12.8 |  | 59.3 ± 12.8 |  | 56.0 ± 13.6 |  | 0.19 | 62.9 ± 12.1 |  | 0.25 | 64.3 ± 9.4 |  | 0.13 |
male | 91 | (53.8%) | 24 | (49.0%) | 29 | (58.0%) | 0.36 | 27 | (54.0%) | 0.61 | 11 | (55.0%) | 0.65 |
cagA | 169 | (100.0%) | 49 | (100.0%) | 50 | (100.0%) | - | 50 | (100.0%) | - | 20 | (100.0%) | - |
vacA s1 | 169 | (100.0%) | 49 | (100.0%) | 50 | (100.0%) | - | 50 | (100.0%) | - | 20 | (100.0%) | - |
vacA m1 | 169 | (100.0%) | 49 | (100.0%) | 50 | (100.0%) | - | 50 | (100.0%) | - | 20 | (100.0%) | - |
hp0967 | 105 | (62.1%) | 30 | (61.2%) | 31 | (62.0%) | 0.93 | 34 | (68.0%) | 0.48 | 10 | (50.0%) | 0.39 |
jhp0045 | 15 | (8.9%) | 2 | (4.1%) | 6 | (12.0%) | 0.14 | 5 | (10.0%) | 0.22 | 2 | (10.0%) | 0.32 |
jhp0046 | 15 | (8.9%) | 2 | (4.1%) | 6 | (12.0%) | 0.14 | 5 | (10.0%) | 0.22 | 2 | (10.0%) | 0.32 |
jhp0951 | 108 | (63.9%) | 31 | (63.3%) | 30 | (60.0%) | 0.73 | 35 | (70.0%) | 0.47 | 12 | (60.0%) | 0.80 |